Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN,
News
NP Institute Concludes in Boston After 4 Days of Practical Clinical Insight for APPs
05/03/2023
Last weekend’s inaugural NP Institute In-Person meeting took attendees through a deep dive into foundational psychopharmacology education.
Last weekend’s inaugural NP Institute In-Person meeting took attendees through a deep dive into foundational psychopharmacology education.
Last weekend’s inaugural NP...
05/03/2023
Psych Congress Network
Antisense Oligonucleotide Reduces Tau Levels in Patients With Mild Alzheimer's
News
Antisense Oligonucleotide Reduces Tau Levels in Patients With Mild Alzheimer Disease
05/01/2023
A tau-targeting antisense oligonucleotide (MAPTRx) reduced cerebrospinal fluid total-tau concentration more than 50%, on average, 6 months after the last dose in patients with mild Alzheimer disease. Researchers published their findings in...
A tau-targeting antisense oligonucleotide (MAPTRx) reduced cerebrospinal fluid total-tau concentration more than 50%, on average, 6 months after the last dose in patients with mild Alzheimer disease. Researchers published their findings in...
A tau-targeting antisense...
05/01/2023
Psych Congress Network

Advertisement

People running on the beach at sunset
News
Physical Fitness Associated With Better Mental Health in Adults With ADHD
05/01/2023
Although mental health was worse in adults with ADHD compared to neurotypical controls, those with higher cardiorespiratory fitness had better mental health, according to findings published in the Journal of Attention Disorders.
Although mental health was worse in adults with ADHD compared to neurotypical controls, those with higher cardiorespiratory fitness had better mental health, according to findings published in the Journal of Attention Disorders.
Although mental health was worse...
05/01/2023
Psych Congress Network
News
Knowing Your Patient is as Important as Knowing Your Psychopharmacology, NP Institute Steering Committee Emphasizes
04/28/2023
The “Principles of Psychopharmacology” session kicked off NP Institute In-Person on Friday afternoon, serving as a deep dive introductory course for advance practice providers (APPs).
The “Principles of Psychopharmacology” session kicked off NP Institute In-Person on Friday afternoon, serving as a deep dive introductory course for advance practice providers (APPs).
The “Principles of...
04/28/2023
Psych Congress Network
News
FDA Approves ABILIFY ASIMTUFII for Schizophrenia and Bipolar Disorder Treatment
04/28/2023
The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 
The FDA approved ABILIFY ASIMTUFII (aripiprazole), a long-acting injectable (LAI) medication for the treatment of schizophrenia and bipolar I disorder. 
The FDA approved ABILIFY...
04/28/2023
Psych Congress Network

Advertisement

News
Stress Linked With Cognitive Decline in Older US Adults
04/27/2023
Results could mean screening for stress in high-risk older adults may be beneficial.
Results could mean screening for stress in high-risk older adults may be beneficial.
Results could mean screening for...
04/27/2023
Psych Congress Network
News
New APA Eating Disorder Guidelines Advise Patient-Centered Care
04/24/2023
This is the first new protocol the board has released since 2006
This is the first new protocol the board has released since 2006
This is the first new protocol...
04/24/2023
Psych Congress Network
News
Four Blood Biomarkers Associated With PTSD in Military Personnel
04/24/2023
Findings were presented at the annual meeting of the American Society for Biochemistry and Molecular Biology in Seattle in March
Findings were presented at the annual meeting of the American Society for Biochemistry and Molecular Biology in Seattle in March
Findings were presented at the...
04/24/2023
Psych Congress Network

Advertisement

News
MDMA-Assisted Therapy for PTSD Demonstrates Durable Response in Long-Term Observational Follow-Up Study
04/24/2023
Preliminary findings from an observational follow-up study released by MAPS Public Benefit Corporation show that participants being treated for PTSD demonstrated a durable response at least 6 months after their last MDMA-assisted therapy...
Preliminary findings from an observational follow-up study released by MAPS Public Benefit Corporation show that participants being treated for PTSD demonstrated a durable response at least 6 months after their last MDMA-assisted therapy...
Preliminary findings from an...
04/24/2023
Psych Congress Network
News
Mothers With Depression Respond Slower to Children, Study Finds
04/24/2023
Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.
Mothers with depression take longer to respond to their infant children than mothers without depression, according to a longitudinal study published in Infant and Child Development.
Mothers with depression take...
04/24/2023
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use